- UPDATE 2-Pfizer, Lilly to resume study testing pain drug Reuters - Markets - Regulatory News
- Pfizer Pockets $200 Million as Tanezumab Phase III Program With Eli Lilly Resumes Bio Space - Breaking News
- Pfizer's $400M Class Action Settlement Gets Early Nod Law 360 Securities
- Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Business Wire Product/Service News
- Pfizer's Hospira deal bets on price spike for specialty generics Reuters - Sectors - Healthcare
- Pfizer to make $17B acquisition The Philadelphia Business Journal - News
- Pfizer Gets Growth Injection with $17 Billion Hospira Deal Fidelity - Merger and Acquision News
- Pfizer buying Hospira for about $15.23 billion The Lansdale Reporter - News
- Pfizer breast cancer drug gets early FDA approval The Uniontown Herald-Standard - More Business
- Pfizer to pay $400 million to avert investor class action trial Reuters - Sectors - Healthcare
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on PFIZER INC
- Rate PFIZER INC on their payment behavior
- Ask your network about PFIZER INC with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.